Which closed-end funds own Precision BioSciences Inc?
3 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $17.5M. Security type: common equity. Country: United States. CUSIP 74019P207 · ISIN US74019P2074 · ticker DTIL.
Holdings are historical filings (report dates May 29, 2026 – Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| THW abrdn World Healthcare Fund | Healthcare | 1.31% | $9M | 1,144,208 sh | $689M | 3.7% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 1.24% | $8.5M | 1,085,970 sh | $690M | 3.4% discount | Jun 30, 2026 |
| GUG Guggenheim Active Allocation Fund | U.S. Equity | 0.00% | $63 | 9 sh | $631M | 12.7% discount | May 29, 2026 |
3 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: PRECISION BIOSCIENCES INC.
Issuer-level search for “DTIL” → · Compare two funds’ portfolios →